Laparoscopy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ambu
AmbuDenmark - Ballerup
1 program
Ambu AuraGain evaluationN/A1 trial
Active Trials
NCT02511652CompletedEst. Dec 2015
Takeda
TakedaTOKYO, Japan
1 program
TachosilN/A1 trial
Active Trials
NCT02685007Completed131Est. Aug 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaTachosil
AmbuAmbu AuraGain evaluation

Clinical Trials (2)

Total enrollment: 131 patients across 2 trials

RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study

Start: Apr 2016Est. completion: Aug 2017131 patients
N/ACompleted
NCT02511652AmbuAmbu AuraGain evaluation

Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery

Start: Jun 2015Est. completion: Dec 2015
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space